• Parkinsonism developed in two patients who were receiving neuroleptic drugs. In each case the clinical manifestations remitted completely when the offending drug or drugs were discontinued. Histologic examination in each patient disclosed abnormalities characteristic of idiopathic paralysis agitans (IPA). Levels of homovanillic acid were low in both cases, and dopamine (DA) levels were measurably reduced in the striatum in one case. It is postulated that before administration of neuroleptic drugs, both patients had preclinical IPA, which predisposed them to parkinsonism when challenged with DA antagonists. Our observations suggest that some patients with irreversible drug-induced parkinsonism may suffer from IPA and that the reversibility of clinical features does not exclude the presence of subclinical IPA.
Rajput AH, Rozdilsky B, Hornykiewicz O, Shannak K, Lee T, Seeman P. Reversible Drug-Induced Parkinsonism: Clinicopathologic Study of Two Cases. Arch Neurol. 1982;39(10):644–646. doi:10.1001/archneur.1982.00510220042009
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.